0001666071-20-000286.txt : 20201110 0001666071-20-000286.hdr.sgml : 20201110 20201110204752 ACCESSION NUMBER: 0001666071-20-000286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201106 FILED AS OF DATE: 20201110 DATE AS OF CHANGE: 20201110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOMERS KIRK CENTRAL INDEX KEY: 0001204015 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 201302736 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_160505925820716.xml FORM 4 X0306 4 2020-11-06 0 0001666071 Cardlytics, Inc. CDLX 0001204015 SOMERS KIRK C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Legal & Privacy Officer Common Stock 2020-11-06 4 S 0 10000 88 D 71012 D Common Stock 2020-11-09 4 M 0 1562 20 A 72574 D Common Stock 2020-11-09 4 M 0 3906 30.44 A 76480 D Common Stock 2020-11-09 4 M 0 420 0 A 76900 D Common Stock 2020-11-09 4 S 0 172 100.27 D 76728 D Employee Stock Option (Right to Buy) 20.0 2020-11-09 4 M 0 1562 0 D 2026-12-06 Common Stock 1562.0 261 D Employee Stock Option (Right to Buy) 30.44 2020-11-09 4 M 0 3906 0 D 2027-07-07 Common Stock 3906.0 3907 D Restricted Stock Units 2020-11-09 4 A 0 420 0 A Common Stock 420.0 420 D Restricted Stock Units 2020-11-09 4 M 0 420 0 D Common Stock 420.0 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on November 9, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. The RSUs are immediately vested. /s/ Kirk L. Somers 2020-11-10